IMARC Group has recently released a report titled “Chronic Urticaria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the chronic urticaria market size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Chronic urticaria represents a common dermal disorder usually characterized by severely inflamed, well-encircled, and swollen welts with sizes that range from a few millimeters to various centimeters or wider. It is generally caused by the secretion of excessive quantities of histamine and other inflammatory mediators in the skin. The diagnosis of chronic urticaria is primarily clinical. In addition to this, a physical examination includes evaluating the pulse rate and characterizing as well as identifying present lesions and their severity with the help of a skin biopsy.
Request a Free Sample Report: https://www.imarcgroup.com/chronic-urticaria-market/requestsample
Market Trend:
The rising prevalence of allergic disorders and infections, owing to numerous associated triggering factors, such as alcohol, heat and friction, diet, mental stress, etc., is primarily driving the chronic urticaria market. Additionally, the growing incidences of autoimmune ailments, such as rheumatoid arthritis, Type 1 diabetes, celiac disease, etc., are further catalyzing the market growth. Besides this, non-governmental organizations (NGOs) and government bodies across countries are launching health education campaigns to generate awareness regarding the psychosocial effects of chronic urticaria, especially stigmatization, which is acting as another significant growth-inducing factor.
Moreover, the introduction of advanced validated instruments that can quantify the severity of the ailment is also positively influencing the global market. Apart from this, the increasing investments in RD activities to evaluate the safety and efficacy, mechanism of action, and dosing of biologics are bolstering the market growth. Furthermore, the inflating popularity of second-generation antihistamines and the development of pharmacological and preventive approaches to control the disabling symptoms suffered by patients are anticipated to fuel the chronic urticaria market over the forecasted period.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the chronic urticaria market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the chronic urticaria market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC List of figures: https://www.imarcgroup.com/chronic-urticaria-market
Key Questions Answered in this Report:
- How has the chronic urticaria market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the chronic urticaria market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the chronic urticaria market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Cystic Fibrosis Market Report 2023-2033
Idiopathic Pulmonary Fibrosis (IPF) Market Report 2023-2033
Diabetic Neuropathy Market Report 2023-2033
Metachromatic Leukodystrophy Market Report 2023-2033
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
